Washington: Vaccine manufacturer Pfizer said on Thursday that it had included in the clinical trial of anti-corona vaccine on children under eleven years of age. This is an early indication of the next phase of the global vaccination campaign. According to the news agency AFP, Pfizer said ‘Together with our partner BioNotech, we vaccinated the first healthy children in a global phase 1/2/3 study to evaluate the safety, tolerability and immunogenicity of the Pfizer-BioNotech COVID-19 vaccine. is.’
The company said that we are proud that we started the vaccine trial. Children and their families are eagerly waiting for this. According to details posted on the site Clintrials.gov, the company is testing three different dosage levels for use in this age group.
Data from Trias expected in the second half of 2021
The company is already testing doses of the anti-corona vaccine in 12 to 15-year-olds. The US Emergency Authority includes people 16 and older. Pfizer, Modern, and AstraZeneca have included young children in their vaccine trials, while Johnson & Johnson is currently planning to begin work on it.
Children are generally at the highest risk of the disease and are less likely to infect the virus than adults. Most experts believe that providing anti-corona vaccines to this age group is very important. Pfizer spokesman Sharon Castillo said that data from Trias is expected in the second half of 2021.
